Product Information
MS417 is a potent antagonist of the protein erythropoietin receptor and has shown to be effective in the treatment of tumor cells. The drug binds to the erythropoietin receptor, blocking the signal transduction pathway that leads to cell proliferation. MS417 has been shown to inhibit tumor growth in an experimental model and is currently being tested in clinical trials for cardiac dysfunction and treatment of HIV infection. It also inhibits the production of histones proteins that are involved in epigenetic regulation of gene expression.
Chemical properties
Technical inquiry about: 3D-RLB48936 MS417
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
